Modified immune cells target rare muscle disease in new trial
Disease control
Not yet recruiting
This study is testing whether a new cell therapy called Descartes-08 can help control symptoms of dermatomyositis and antisynthetase syndrome, rare autoimmune diseases that cause muscle weakness and skin rashes. The trial will enroll 60 adults whose symptoms haven't improved enou…
Phase: PHASE2 • Sponsor: Cartesian Therapeutics • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC